Aeterna Zentaris
AEZS
#10806
Rank
A$25.08 M
Marketcap
A$8.19
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$2.93. In 2022 the company made an earnings per share (EPS) of A-$6.70 a decrease over its 2021 EPS that were of A-$2.61.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$6.70157.14%
2021A-$2.61-41.48%
2020A-$4.45-64.46%
2019A-$12.53-240%
2018A$8.95-122.32%
2017A-$40.10-53.53%
2016A-$86.28-86.71%
2015A-$649.46-35.21%
2014A-$1,002-216.67%
2013A$859.26-123.3%
2012A-$3,688-40.8%
2011A-$6,230-6.45%
2010A-$6,659-27.91%
2009A-$9,237-61.61%
2008A-$24,05983.61%
2007A-$13,104-195.31%
2006A$13,748178.26%
2005A$4,941-330%
2004A-$2,148-80.05%
2003A-$10,76717.78%
2002A-$9,142515.93%
2001A-$1,484-68.6%
2000A-$4,727119.62%
1999A-$2,153-3.63%
1998A-$2,234

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$9.54-425.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$2.73-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$6.50-321.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.52-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$5.04-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA